LWA.F ECO ANIMAL HLTH GR.LS-05
- Market cap
- EUR 62.7M
- P/E
- 23.5x
- P/B
- 0.61x
- ROE
- 2.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is LWA.F undervalued?
Graham numberLWA.F trades 20.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ECO ANIMAL HLTH GR.LS-05 fundamental analysis
No fundamental analysis for ECO ANIMAL HLTH GR.LS-05 yet.
ECO ANIMAL HLTH GR.LS-05 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ECO ANIMAL HLTH GR.LS-05
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
Full company profileECO ANIMAL HLTH GR.LS-05 financial statements
ECO ANIMAL HLTH GR.LS-05 annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 82.2M | 85.3M | 89.4M | 79.6M | 87.5M |
| Gross Profit | 35.1M | 38.4M | 37.7M | 35.9M | 42.5M |
| Operating Income | 3.53M | 4.95M | 4.19M | 3.35M | 5.72M |
| EBITDA | - | 7.45M | 6.53M | 7.29M | 8.50M |
| Net Income | -686K | 1.01M | 1.05M | 1.69M | 2.19M |
| EPS | -0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Balance Sheet | |||||
| Total Assets | 114M | 121M | 123M | 121M | 119M |
| Total Liabilities | 19.3M | 25.8M | 29.9M | 25.8M | 23.1M |
| Shareholders' Equity | 82.1M | 83.3M | 83.7M | 85.5M | 87.1M |
| Cash & Short-term Investments | 14.3M | 21.7M | 22.4M | 25.0M | 25.4M |
| Cash Flow | |||||
| Operating Cash Flow | -548K | 15.9M | 9.42M | 10.4M | 7.66M |
| Capital Expenditure | 2.89M | 5.98M | 4.62M | 5.00M | 3.78M |
| Free Cash Flow | -3.44M | 9.93M | 4.79M | 5.44M | 3.88M |
| Ratios | |||||
| ROE | -0.8% | 1.2% | 1.3% | 2.0% | 2.5% |
| ROA | -0.6% | 0.8% | 0.9% | 1.4% | 1.8% |
| Net Profit Margin | -0.8% | 1.2% | 1.2% | 2.1% | 2.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ECO ANIMAL HLTH GR.LS-05 dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- 113.9%
- Ex-dividend date
- Sep 23, 2021
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | GBP 2.49M | 0.04 | 113.9% |
| 2025 | GBP 1.07M | 0.02 | 63.2% |
| 2024 | GBP 2.81M | 0.04 | 268.4% |
| 2023 | GBP 1.81M | 0.03 | 179.6% |
| 2022 | GBP 2.89M | 0.04 | - |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns ECO ANIMAL HLTH GR.LS-05
- Insiders 16.37%
- Institutions 65.98%
- Public & others 17.65%
- Shares outstanding 66.7M
- Free float 59.3M
ECO ANIMAL HLTH GR.LS-05 company profile
- Company name
- ECO ANIMAL HLTH GR.LS-05
- Ticker
- LWA.F
- ISIN
- GB0032036807
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 213
- Fiscal year end
- March
- Address
- The Grange, London, United Kingdom, N14 6BN
- Phone
- 44 208 447 8899
- Website
- ecoanimalhealth.com
About ECO ANIMAL HLTH GR.LS-05
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
ECO ANIMAL HLTH GR.LS-05 management
4- Dr. David Charles HallasCEO & Director · born 1964
- Mr. Christopher John Wilks ACA, BSc, F.C.A.CFO, Finance Director, Secretary & Director · born 1964
- Mr. Andrew BuglassChief Commercial Officer
- Dr. Andrew WinderHead of Business Development